Skip to content

Neuronetics STIM Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
CVRx, Inc. logo
CVRx, Inc.CVRX
Neuropace, Inc. logo
Neuropace, Inc.NPCE
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's deferred tax assets and other non-current assets?
Neuronetics (STIM) reported deferred tax assets and other non-current assets of $2.25M in Q1 2026.
How has Neuronetics's deferred tax assets and other non-current assets changed year-over-year?
Neuronetics's deferred tax assets and other non-current assets increased by 10.5% year-over-year, from $2.04M to $2.25M.
What is the long-term trend for Neuronetics's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Neuronetics's deferred tax assets and other non-current assets has grown at a 1.2% compound annual growth rate (CAGR), from $1.87M to $1.98M.